The highly selective CDK9 inhibitor, AZD4573, induced apoptosis and subsequent cell death in hematologic cancer models in vitro and favored tumor regression in tumor xenografts in vivo, through the indirect inhibition of Mcl-1 [161]. The gene discussed is CDK9; the disease is neoplasm.